What does CUSIP 68062P106 represent in this 13F holders report?

CUSIP 68062P106 is the security identifier for OLMA - Olema Pharmaceuticals, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held OLMA - Olema Pharmaceuticals, Inc. - COMMON STOCK in Q1 2026?

193 institutional investors reported OLMA - Olema Pharmaceuticals, Inc. - COMMON STOCK for Q1 2026. Use the holders table for investor-level position and value details.

Olema Pharmaceuticals, Inc. - COMMON STOCK (OLMA)

CUSIP: 68062P106

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / COMMON STOCK
Total 13F shares: 101,411,965
Total 13F value: $1,511,791,691
Share change: +9,862,300
Put/Call ratio: 24%
SEC-reported price per share: $14.91
Number of holders: 193
Value change: +$99,305,974
Number of buys: 110
Number of sells: 98
Shares outstanding: 87,500,447

Security key

68062P106

Report period

Q1 2026

Institutions

193

Top holders

OLMA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Olema Pharmaceuticals, Inc. SEC filings Olema Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 68062P106

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of OLMA - Olema Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Paradigm Biocapital Advis...

Disclosed value leader

Bain Capital Life Science...

Comparable rows

15/15

Latest evidence

31 Mar 2026

13F 13D/G 3/4/5 Lead comparable stake: 10% 13D/G row: Paradigm Biocapital Advisors LP Showing 1-6 of 15 holder rows.

Quick read

Paradigm Biocapital Advisors LP leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Paradigm Biocapital Advisors LP's linked filing trail.

Comparable ownership Top 5

Paradigm Biocapital Advisors LP 10%

Janus Henderson Group Ltd. 8.2%

Bain Capital Life Sciences Opport... 8.2%

Invus Global Management, LLC 5.1%

Logos Global Management LP 4.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Paradigm Biocapital Advisors LP	13F 13D/G 3/4/5 Company · 10%+ Owner 13F 13D/G 3/4/5	10% from 13D/G	$188,604,300 7,544,172 shares	—	31 Dec 2025
Janus Henderson Group Ltd.	13F 13D/G Company · JANUS HENDERSON GROUP PLC 13F 13D/G	8.2% from 13D/G	$167,901,108 6,710,194 shares	—	31 Dec 2025
Bain Capital Life Sciences Opportunities IV, L.P.	13D/G 13D/G	8.2%	$111,425,979 7,473,238 shares	-$15,437,859	31 Mar 2026
Invus Global Management, LLC	13D/G Raymond Debbane 13D/G	5.1%	$108,693,078 4,461,949 shares	$0	16 Mar 2026
Logos Global Management LP	13F 13D/G Company 13F 13D/G	4.7% from 13D/G	$80,221,875 3,208,875 shares	—	31 Dec 2025
Point72 Asset Management, L.P.	13D/G 13F Company 13D/G 13F	2.3%	$7,781,412 1,543,931 shares	$0	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

193

101,411,965

Rows available

193

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

193

Q1 2026 holders

193

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend